Reducing aztreonam/avibactam waste: insights from Monte Carlo simulations
Lowering the LD in patients with preserved renal function had only a short-lived impact on early exposure and did not compromise PK/PD performance. These results support dose adaptation to reduce unnecessary drug waste.
Authors
- Cyrielle Codde (ORCID: https://orcid.org/0009-0003-3831-1904)
- Yeleen Fromage (ORCID: https://orcid.org/0009-0002-3356-557X)
- Jean‐Baptiste Woillard (ORCID: https://orcid.org/0000-0003-1695-0695)
- Caroline Monchaud (ORCID: https://orcid.org/0000-0002-9637-5813)
- Marc Labriffe (ORCID: https://orcid.org/0000-0001-5840-8904)
- Hamza Sayadi
Institutions
- Inserm (FR)
- Hôpital Dupuytren (FR)
- Université de Limoges (FR)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2025-10-29
- DOI
- https://doi.org/10.1093/jac/dkaf421
- Citations
- 1
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.43